The effect of concentration of guanidine hydrochloride on the sulfasalazine–serum albumin complex

A detailed study of the effect of Gu·HCl concentration is presented in this work. Destabilization of the tertiary structure of BSA was observed by using fluorescence measurements of excitation wavelength of 280 and 295 nm. We ascertained that in terms of the effect on the fluorescence emission spectrum of BSA, Gu·HCl concentration falls into three regions: I, 0.1–1.6 M; II, 1.6–3 M and III, 3–6 M. The intermediate state of BSA denaturation for 1.6–1.7 M Gu·HCl was noticed. Quenching of the native BSA fluorescence by sulfasalazine (SSZ), a drug used in inflammatory bowel disease, was shown. In the presence of Gu·HCl, BSA fluorescence rises or decreases depending on the concentration region I or II, respectively. A similar effect of Gu·HCl on the fluorescence spectrum of BSA, quenched by sulfasalazine, can be found. However, Gu·HCl concentration-dependent reduction of the quenching effect of the SSZ points to the gradual loss of the binding properties. Binding and quenching constants for the SSZ–BSA complexes were calculated in the absence and presence of the denaturant. Since Gu·HCl at concentration 0.1–1.6 M increases and at concentration 1.6–3 M decreases the BSA fluorescence, the mechanism of the destabilization of the native structure of serum albumin differs for these two ranges of Gu·HCl concentration. The small concentration of the denaturant causes a disorder in the hydration layer of the albumin and the higher one causes the binding of the denaturant molecule close to the Trp 135 in the IB subdomain.